BioCentury
ARTICLE | Company News

Medytox, Allergan deal

January 13, 2014 8:00 AM UTC

The companies closed a September 2013 licensing deal granting Allergan exclusive, worldwide rights outside of Korea to develop and commercialize undisclosed neurotoxin products from Medytox (see BioCe...